查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1758802

光甘草定 CAS 59870-68-7 的全球市场

Glabridin CAS 59870-68-7
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 284 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，光甘草定 CAS 59870-68-7 的全球市场规模将达到 345 亿美国

全球光甘草定（CAS 59870-68-7）市场规模预计在2024年达到275亿美元，预计到2030年将达到345亿美元，2024年至2030年的复合年增长率为3.8%。报告分析的细分市场之一－高效液相层析20%细分市场，预计其复合年增长率为4.9%，到分析期结束时市场规模将达到123亿美元。此外，在分析期内，高效液相层析40%细分市场预计其复合年增长率为3.6%。

美国市场规模估计为 75 亿美元，中国市场预计复合年增长率为 7.3%

美国光甘草定预计（CAS 59870-68-7）市场规模将在2024年达到75亿美元。预计到2030年，全球第二大经济体中国市场规模将达到70亿美元，在2024-2030年的分析期间内，复合年增长率为7.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.5%和3.0%。在欧洲，预计德国市场的复合年增长率为2.2%。

全球「光甘草定 (CAS 59870-68-7)」市场趋势及驱动因素概述

为什么光甘草定会成为化妆品和保健品产业抢手的成分？

光甘草定是一种主要从甘草根（Glycyrrhiza glabra）中提取的类黄酮化合物，因其强大的美白、抗氧化、抗炎和抗衰老功效，正迅速在全球营养保健品和化妆品行业引起关注。随着消费者偏好转向天然成分，光甘草定作为经科学检验的植物性替代物，在替代对苯二酚和曲酸等合成活性成分方面脱颖而出，尤其是在针对色素沉着过度、黄褐斑和肤色不均的护肤配方中。该化合物能够抑制酪胺酸酶活性（酪胺酸酶是黑色素生成的关键），使其成为亮白护肤产品的理想成分。此外，光甘草定无刺激性，适用于敏感肌肤，并已证实具有对抗紫外线诱导的氧化压力的保护作用，这进一步增强了效用。除了化妆品领域，光甘草定也因其雌激素、心血管和神经保护功效，正在被探索应用于机能性食品和营养保健品中。这些应用尤其适合关注女性健康和更年期问题的市场。洁净标示配方意识的不断提升、草本活性成分活性化的不断加强以及新兴经济体可支配收入的不断增长，进一步推动了市场需求。随着自然美容和健康趋势在亚太、欧洲和北美地区成为主流，光甘草定作为一种具有多方面健康和美容功效的优质生物活性成分，正在开拓其细分市场。

光甘草定市场的主要技术和製造趋势是什么？

光甘草定的萃取、精製和製剂技术创新在提高其商业性价值和扩充性发挥关键作用。传统上，光甘草定是使用乙醇或水醇溶剂从甘草根中提取的，但现在受益于先进的超临界 CO2萃取方法，可产生更高的纯度并更有效地保持生物活性。这种更环保、更有效率的萃取技术符合日益增长的监管和消费者对永续采购和环保加工的需求。在製剂领域，奈米胶囊和脂质体递送系统已被用于提高光甘草定的稳定性、生物利用度和经皮吸收。这些技术有助于克服水溶性差和局部应用中潜在降解等挑战。在生产方面，生物技术驱动的发酵和植物细胞培养技术已成为传统培养和提取的潜在替代方案，可在最大限度减少环境影响的同时实现可控和稳定的供应。此外，高活性含量（40% 或更高）的标准化光甘草定萃取物也正在开发中，以满足药品和化妆品配方的纯度要求。严格的品管和可追溯机制正日益被采用，以确保符合安全性和功效标准，尤其是在出口到日本、韩国和欧盟方面。这些技术进步不仅使供应商能够提高产品性能，也有助于满足竞争激烈的全球市场对高品质、洁净标示成分日益增长的需求。

最终用途部门和区域市场如何影响需求模式？

光甘草定市场受到几个主要终端使用领域的强劲需求所驱动，包括化妆品和个人护理、营养保健品和药品。在化妆品领域，光甘草定广泛用于美白霜、抗衰老精华、防晒油和痤疮后修復产品，使个人护理领域成为这种化合物的最大消费者。韩国、中国、日本和印度等国家在推出含有光甘草定的产品方面处于领先地位。西方市场，尤其是欧洲和北美，光甘草定在清洁美容和植物来源药妆中的应用日益增多，在这些市场中，光甘草定通常作为优质抗衰老和敏感肌肤产品系列的一部分出售。在营养保健品领域，光甘草定被配製成补充剂，旨在管理METABOLIC INC.症候群、更年期症状和心血管健康，这使其对老龄化社会尤其具有吸引力。药物研究也正在探索光甘草定在发炎和荷尔蒙相关疾病中的应用，儘管其中大多数仍处于研究阶段。在经销方面，B2B（大宗萃取物供应商、化妆品原料公司）和B2C（成品品牌）通路都在不断拓展。中国、欧盟和美国对植物萃取物监管的清晰化，进一步促进了市场准入和产品核可。电子商务的成长正在刺激跨境需求，消费者也越来越寻求有临床依据的天然活性成分。产业创新与区域动态的融合，正在改变光甘草定在全球的定位与消费方式。

哪些因素推动了全球光甘草定市场的成长？

光甘草定 (CAS 59870-68-7) 市场的成长受到多种相互关联的因素驱动，包括产业变化、消费行为和产品配方创新。其中最重要的是全球对天然植物来源化妆品活性成分日益增长的需求，这些成分能够有效美化皮肤，而没有合成成分的副作用。随着消费者越来越注重成分，光甘草定在减少色素沉着和氧化压力方面的已证实功效使其成为一个强大的价值提案。其次，抗衰老和美白产品日益普及，尤其是在亚太地区和中东地区，这推动了对强效植物成分的需求。第三，人口老化和对荷尔蒙平衡和代谢健康的兴趣推动了机能性食品和补充剂市场的扩张，这为可摄取形式的光甘草定开闢了新的使用案例。在供应方面，萃取和生物技术的进步正在提高成本效率和扩充性，使製造商能够在保持高纯度标准的同时满足不断增长的全球需求。洁净标示和纯素认证产品的日益普及，也为光甘草定等植物成分创造了有利的监管和消费环境。此外，品牌在研发、临床检验和行销方面的投入，也提升了光甘草定製剂的可信度和认知度。最后，在中国、印度和中欧等全球采购基地的支持下，这种草药成分的国际贸易正在扩大。这些综合的市场驱动因素使光甘草定成为天然化妆品和营养保健品市场的高成长成分，无论在成熟经济体或新兴经济体，都拥有巨大的未来潜力。

部分

类型（HPLC 20%、HPLC 40%、HPLC 60%、高效液相层析90%、HPLC 98%）、用途（化妆品用途、医药用途）

受访公司范例（44家值得关注的公司）

  • AIDP, Inc.
  • Alchem International
  • Alfa Chemicals
  • Anthony Ingredients
  • BOC Sciences
  • Botanic Innovations
  • ChemFaces
  • Chromadex, Inc.
  • CP Kelco
  • Euromed SA
  • FloraTech
  • Galaxy Surfactants
  • Givaudan
  • Guangxi Wuzhou Zhongheng Bio-Tech
  • Hebei Yele Biotechnology
  • Indena SpA
  • Jiangxi Shenzhou Biological
  • Layn Natural Ingredients
  • Lonza Group AG
  • Natreon, Inc.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP36999

Global Glabridin CAS 59870-68-7 Market to Reach US$34.5 Billion by 2030

The global market for Glabridin CAS 59870-68-7 estimated at US$27.5 Billion in the year 2024, is expected to reach US$34.5 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. HPLC 20 percent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the HPLC 40 percent segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.5 Billion While China is Forecast to Grow at 7.3% CAGR

The Glabridin CAS 59870-68-7 market in the U.S. is estimated at US$7.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global "Glabridin (CAS 59870-68-7)" Market - Key Trends & Drivers Summarized

Why Is Glabridin Emerging as a High-Demand Ingredient in the Cosmetics and Health Industry?

Glabridin, a flavonoid compound extracted primarily from licorice root (Glycyrrhiza glabra), is rapidly gaining prominence in the global nutraceutical and cosmetics industries due to its potent skin-lightening, antioxidant, anti-inflammatory, and anti-aging properties. As consumer preference shifts toward naturally derived ingredients, glabridin stands out as a scientifically validated botanical alternative to synthetic actives like hydroquinone or kojic acid, especially in skincare formulations targeting hyperpigmentation, melasma, and uneven skin tone. The compound inhibits tyrosinase activity, which is responsible for melanin production, making it a go-to ingredient in brightening and whitening skincare products. In addition, glabridin is non-irritating, suitable for sensitive skin, and has demonstrated protective effects against UV-induced oxidative stress, further reinforcing its utility in anti-aging and sun care formulations. Beyond cosmetics, glabridin is also explored in functional foods and dietary supplements for its estrogenic, cardiovascular, and neuroprotective benefits. These applications are particularly relevant in markets focused on women’s health and anti-menopausal support. The growing awareness of clean-label formulations, increased R&D into herbal actives, and rising disposable income in emerging economies are further boosting demand. As natural beauty and wellness trends become mainstream across Asia-Pacific, Europe, and North America, glabridin is carving out a niche as a premium bioactive with multifunctional health and cosmetic benefits.

What Are the Key Technological and Manufacturing Trends in the Glabridin Market?

Technological innovation in the extraction, purification, and formulation of glabridin is playing a critical role in enhancing its commercial value and scalability. Traditionally extracted from licorice root using ethanol or water-alcohol solvents, glabridin now benefits from advanced supercritical CO2 extraction methods that yield higher purity and retain bioactivity more effectively. These greener and more efficient extraction techniques align with rising regulatory and consumer demand for sustainable sourcing and environmentally friendly processing. In the realm of formulation, nanoencapsulation and liposomal delivery systems are being adopted to enhance glabridin’s stability, bioavailability, and dermal absorption. These technologies help overcome challenges like low water solubility and potential degradation in topical applications. On the production side, biotech-based fermentation and plant cell culture techniques are emerging as potential alternatives to traditional farming and extraction, enabling controlled, consistent supply while minimizing environmental impact. Manufacturers are also developing standardized glabridin extracts with high active content (≥40%) to meet the purity requirements of pharmaceutical and cosmeceutical formulations. Stringent quality control and traceability mechanisms-especially for exports to Japan, South Korea, and the European Union-are increasingly being adopted to ensure compliance with safety and efficacy standards. These technological advancements not only improve product performance but also allow suppliers to meet the growing demand for high-quality, clean-label ingredients in a competitive global market.

How Are End-Use Sectors and Geographic Markets Influencing Demand Patterns?

The glabridin market is driven by strong demand from several key end-use sectors, notably cosmetics and personal care, dietary supplements, and pharmaceuticals. In cosmetics, glabridin is used extensively in skin whitening creams, anti-aging serums, sunscreens, and post-acne recovery products-making the personal care sector the largest consumer of this compound. Asia-Pacific remains the dominant market due to cultural emphasis on skin brightness and even complexion, with countries like South Korea, China, Japan, and India leading in product launches containing glabridin. Western markets, particularly in Europe and North America, are seeing increased adoption of glabridin in clean beauty and plant-based cosmeceuticals, often marketed as part of premium anti-aging and sensitive skin product lines. In the nutraceutical sector, glabridin is incorporated into supplements aimed at managing metabolic syndrome, menopause symptoms, and cardiovascular health, appealing particularly to aging populations. Pharmaceutical research is also exploring glabridin for potential applications in inflammatory disorders and hormone-related conditions, although these remain largely in the investigational stages. In terms of distribution, both B2B (bulk extract suppliers, cosmetic ingredient companies) and B2C (finished product brands) channels are expanding. Regulatory clarity around botanical extracts in China, the EU, and the U.S. is further facilitating market entry and product approvals. E-commerce growth is accelerating demand across borders, as consumers increasingly seek natural actives with clinical backing. This convergence of industry innovation and regional dynamics is reshaping how glabridin is positioned and consumed globally.

What Factors Are Fueling Growth in the Global Glabridin Market?

The growth in the glabridin (CAS 59870-68-7) market is driven by several interconnected factors tied to industry shifts, consumer behavior, and innovation in product formulation. Foremost is the rising global demand for natural, plant-derived cosmetic actives that offer effective skin benefits without the adverse effects associated with synthetic ingredients. As consumers become more ingredient-conscious, glabridin’s proven efficacy in reducing pigmentation and oxidative stress offers a strong value proposition. Second, the increasing popularity of anti-aging and skin-brightening products-particularly in Asia-Pacific and the Middle East-is fueling demand for high-efficacy botanical ingredients, with glabridin positioned as a premium option. Third, the expansion of functional food and supplement markets-driven by the aging population and interest in hormonal balance and metabolic health-is opening new use cases for glabridin in ingestible formats. On the supply side, advancements in extraction and bioengineering technologies are improving cost-efficiency and scalability, allowing manufacturers to meet rising global demand while maintaining high purity standards. The proliferation of clean-label and vegan-certified products is also creating a favorable regulatory and consumer environment for botanical ingredients like glabridin. Additionally, brand investments in R&D, clinical validation, and marketing are strengthening the credibility and visibility of glabridin-based formulations. Finally, international trade in herbal ingredients is expanding, supported by global sourcing hubs in China, India, and Central Europe. These combined drivers are positioning glabridin as a high-growth ingredient in the broader natural cosmetics and nutraceuticals market, with strong future potential across both established and emerging economies.

SCOPE OF STUDY:

The report analyzes the Glabridin CAS 59870-68-7 market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent, HPLC 98 percent); Application (Cosmetics Application, Pharmaceuticals Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • AIDP, Inc.
  • Alchem International
  • Alfa Chemicals
  • Anthony Ingredients
  • BOC Sciences
  • Botanic Innovations
  • ChemFaces
  • Chromadex, Inc.
  • CP Kelco
  • Euromed S.A.
  • FloraTech
  • Galaxy Surfactants
  • Givaudan
  • Guangxi Wuzhou Zhongheng Bio-Tech
  • Hebei Yele Biotechnology
  • Indena S.p.A.
  • Jiangxi Shenzhou Biological
  • Layn Natural Ingredients
  • Lonza Group AG
  • Natreon, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Glabridin CAS 59870-68-7 - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Natural Skin-Lightening Agents Drives Adoption of Glabridin in Cosmetics
    • Growth in Clean Beauty and Botanical Ingredients Strengthens Market for Glabridin-Based Products
    • Scientific Research Validating Anti-Inflammatory Properties Throws Spotlight on New Therapeutic Uses
    • Expansion of Nutricosmetics Segment Accelerates Formulation of Oral Glabridin Supplements
    • Increased Consumer Preference for Non-Hydroquinone Solutions Sustains Demand for Safe Alternatives
    • Regulatory Acceptance of Plant-Based Actives Enhances Formulation Flexibility for Manufacturers
    • Growth in K-Beauty and Functional Skincare Trends Propels Use of Flavonoid-Based Ingredients
    • Limited Raw Material Sources and Cost of Purification Create Challenges in Large-Scale Production
    • Formulation Synergies with Vitamin C and Niacinamide Expand Glabridins Multi-Functional Appeal
    • E-Commerce and Indie Brand Growth Drive Inclusion in Niche Skincare Lines
    • Research into Antioxidant and Estrogenic Properties Expands Opportunities in Wellness Applications
    • High Purity Ingredient Demand from Global Markets Encourages Standardized Extraction Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Glabridin CAS 59870-68-7 Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for HPLC 20 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for HPLC 20 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for HPLC 20 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for HPLC 40 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for HPLC 40 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for HPLC 40 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for HPLC 60 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for HPLC 60 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for HPLC 60 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for High-Performance Liquid Chromatography 90 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for High-Performance Liquid Chromatography 90 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for High-Performance Liquid Chromatography 90 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for HPLC 98 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for HPLC 98 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for HPLC 98 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cosmetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • CHINA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • INDIA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030

IV. COMPETITION